Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-006506
Filing Date
2024-08-26
Accepted
2024-08-26 16:25:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4785
  Complete submission text file 0001950047-24-006506.txt   6332
Mailing Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 (415) 660-5320
Nurix Therapeutics, Inc. (Subject) CIK: 0001549595 (see all company filings)

EIN.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1130
Type: 144 | Act: 33 | File No.: 001-39398 | Film No.: 241241686
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O NURIX THERAPEUTICS, INC. 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address
van Houte Hans (Reporting) CIK: 0001817217 (see all company filings)

Type: 144